Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.750 | 1.000 | 11 | 2011 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.750 | 1.000 | 8 | 2011 | 2019 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Glioblastoma
|
281 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 3 | 2015 | 2018 | |||||
Glioblastoma Multiforme
|
186 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 3 | 2015 | 2018 | |||||
Glioma
|
353 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.700 | 1.000 | 3 | 2015 | 2018 | |||||
Renal Cell Carcinoma
|
288 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.030 | 1.000 | 3 | 2016 | 2019 | |||||
Thyroid carcinoma
|
145 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.720 | 1.000 | 3 | 2016 | 2019 | |||||
Central Nervous System Neoplasms
|
72 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.700 | 1.000 | 2 | 2015 | 2017 | |||||
Chronic Lymphocytic Leukemia
|
291 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.800 | 1.000 | 2 | 2013 | 2019 | |||||
estrogen receptor-negative breast cancer
|
40 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||
Malignant neoplasm of ovary
|
315 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Malignant neoplasm of thyroid
|
103 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
ovarian neoplasm
|
757 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.710 | 1.000 | 2 | 2016 | 2017 | |||||
Papillary thyroid carcinoma
|
204 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2013 | 2019 | |||||
Systolic Pressure
|
1931 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.700 | 1.000 | 2 | 2018 | 2019 | |||||
Thyroid Neoplasm
|
135 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.020 | 1.000 | 2 | 2016 | 2019 | |||||
Adult type dermatomyositis
|
31 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Carcinoma of lung
|
1204 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Chronic Obstructive Airway Disease
|
852 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Clear-cell metastatic renal cell carcinoma
|
11 | 0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 | 0.010 | 1.000 | 1 | 2016 | 2016 |